Medidata and the National Cancer Institute Extend 15-Year Partnership for an Additional Five Years

-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry,  announced an extension ...

October 05, 2023 | Thursday | News
Malaysia's Fight Against Cardiovascular Disease

Cardiovascular diseases (CVDs) present a substantial global health concern, and Malaysia, is not immune to this health issue. As reported by the World Heal...

October 05, 2023 | Thursday | News
QIAGEN Unveils QuantiFERON-EBV RUO Assay for Epstein-Barr Virus Research

QIAGEN  announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in ...

October 05, 2023 | Thursday | News
Thailand Emerges as a Hub for Cancer Immunotherapy Talent, Boosting Advanced Research

Thailand Hub of Talents in Cancer Immunotherapy (TTCI), funded by the National Research Council of Thailand (NRCT), has been recently launched by ...

October 04, 2023 | Wednesday | News
Oxford BioTherapeutics Announces Boehringer Ingelheim's Fast Track Status for Cancer Treatment

BI 764532 is an investigational T-cell engager that redirects T cells towards cancer cells expressing the DLL3 protein DLL3 was discovered using OBT&rsq...

October 04, 2023 | Wednesday | News
Jubilant Radiopharma and Cardiac Imaging Announce Exclusive Mobile Cardiac PET Partnership

“This partnership with Cardiac Imaging allows unprecedented access of RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator...

October 02, 2023 | Monday | News
Everest Medicines Secures Taiwan Approval for XERAVA® in Treating Complicated Intra-Abdominal Infections in Adults

"The NDA approval of XERAVA® in Taiwan marks an important step towards bringing this novel, critical therapy for complicated intra-abdominal infections...

September 28, 2023 | Thursday | News
Mdxhealth Collaborates with University of Oxford to Study GPS Test's Link to Post-Treatment Prostate Cancer Progression

MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision diagnostics company, today announced a research collaboration with the Universit...

September 27, 2023 | Wednesday | News
Novartis' Lutathera® Shows Significant Progression-Free Survival in GEP-NETs

Phase III NETTER-2 trial met primary endpoint of improvement in progression-free survival (PFS) and key secondary endpoint of objective response rate (OR...

September 26, 2023 | Tuesday | News
Valo Health and Novo Nordisk to Collaborate on AI-Driven Cardiometabolic Treatments

Novo Nordisk licenses three preclinical drug discovery programmes in cardiovascular diseases discovered and developed by Valo using the Opal Computational ...

September 26, 2023 | Tuesday | News
Novo Holdings Acquires Paratek Pharmaceuticals to Advance Antimicrobial Resistance Strategy

Paratek's successful commercialization platform to advance novel therapies developed organically and through acquisitions Paratek adds 'final-mile' capa...

September 25, 2023 | Monday | News
MGI Partners with Gencell to Expand Genomics in Latin America

The healthcare landscape in Latin America is currently a worldwide priority. Factors such as increasing awareness of precision medicine, the growing preval...

September 25, 2023 | Monday | News
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic r...

September 21, 2023 | Thursday | News
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer

Located in Sapporo, Japan, Hokkaido University Hospital stands as one of the most prominent medical institutions in the country. Affiliated with Hokkaido U...

September 20, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close